Limited coverage criteria – trandolapril

Last updated on March 24, 2025

 

Return to Special Authority drug list   

Generic name

trandolapril                                                                                                                                               

Strength & form

0.5 mg, 1 mg, 2 mg, 4 mg capsule

Special Authority criteria

Approval period

Treatment failure on optimal doses of or intolerance to ramipril

OR

Complex patient requiring medications for co-existing chronic condition(s)

Indefinite

Practitioner exemptions

Practitioners in the following specialties are not required to submit a Special Authority request for coverage:

  • Pediatric cardiology
  • Pediatrics

Special notes

  • Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria
  • PharmaCare does not cover in trandolapril in combination with verapamil

Special Authority request form(s)